Literature DB >> 16942932

Increased arterial wall stiffness in primary aldosteronism in comparison with essential hypertension.

Branislav Strauch1, Ondrej Petrák, Dan Wichterle, Tomás Zelinka, Robert Holaj, Jirí Widimský.   

Abstract

BACKGROUND: Aldosterone has been shown to substantially contribute to the accumulation of collagen fibers and growth factors in the arterial wall, which can increase wall stiffness. This study aimed at comparing arterial stiffness between patients with primary aldosteronism (PA), essential hypertension (EH), and normotensive controls using carotid-femoral pulse wave velocity (PWV) and central augmentation index (AI).
METHODS: Thirty-six patients with confirmed PA, 28 patients with EH, and 20 normotensive subjects were investigated by Sphygmocor applanation tonometer.
RESULTS: The office blood pressure (BP) at the time of the measurement (PA 167+/-34/92+/-12 mm Hg; EH 166+/-19/91+/-10 mm Hg), age, body mass index (BMI), cholesterol, triglyceride, blood glucose levels were comparable between PA and EH groups. The patients with PA had significantly higher PWV than the EH patients and control subjects (9.8+/-2.6 m/sec v 7.5+/-1.0 m/sec v 5.9+/-0.7 m/sec, respectively; all mutual differences P<.001). The difference in PWV between PA and EH remained statistically significant also after the adjustment for all clinical variables including 24-h BP using multivariate analysis (P=.001).
CONCLUSIONS: Arterial wall stiffness is independently increased in PA compared to EH. This could be caused by the deleterious effects of aldosterone excess (potentially modulated by hypernatremia) on the fibrosis and remodeling of the arterial wall.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16942932     DOI: 10.1016/j.amjhyper.2006.02.002

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  27 in total

Review 1.  Noninvasive measurement of central vascular pressures with arterial tonometry: clinical revival of the pulse pressure waveform?

Authors:  Matthew R Nelson; Jan Stepanek; Michael Cevette; Michael Covalciuc; R Todd Hurst; A Jamil Tajik
Journal:  Mayo Clin Proc       Date:  2010-05       Impact factor: 7.616

2.  Alterations in vascular function in primary aldosteronism: a cardiovascular magnetic resonance imaging study.

Authors:  P B Mark; S Boyle; L U Zimmerli; E P McQuarrie; C Delles; E M Freel
Journal:  J Hum Hypertens       Date:  2013-07-25       Impact factor: 3.012

3.  Eplerenone improves endothelial function and arterial stiffness and inhibits Rho-associated kinase activity in patients with idiopathic hyperaldosteronism: a pilot study.

Authors:  Shinji Kishimoto; Kenji Oki; Tatsuya Maruhashi; Masato Kajikawa; Shogo Matsui; Haruki Hashimoto; Yuji Takaeko; Yasuki Kihara; Kazuaki Chayama; Chikara Goto; Yoshiki Aibara; Farina Mohamad Yusoff; Ayumu Nakashima; Kensuke Noma; James K Liao; Yukihito Higashi
Journal:  J Hypertens       Date:  2019-05       Impact factor: 4.844

4.  Low-Dose Mineralocorticoid Receptor Blockade Prevents Western Diet-Induced Arterial Stiffening in Female Mice.

Authors:  Vincent G DeMarco; Javad Habibi; Guanghong Jia; Annayya R Aroor; Francisco I Ramirez-Perez; Luis A Martinez-Lemus; Shawn B Bender; Mona Garro; Melvin R Hayden; Zhe Sun; Gerald A Meininger; Camila Manrique; Adam Whaley-Connell; James R Sowers
Journal:  Hypertension       Date:  2015-05-26       Impact factor: 10.190

Review 5.  Vascular Smooth Muscle Remodeling in Conductive and Resistance Arteries in Hypertension.

Authors:  Isola A M Brown; Lukas Diederich; Miranda E Good; Leon J DeLalio; Sara A Murphy; Miriam M Cortese-Krott; Jennifer L Hall; Thu H Le; Brant E Isakson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-09       Impact factor: 8.311

6.  Smooth muscle cell mineralocorticoid receptors are mandatory for aldosterone-salt to induce vascular stiffness.

Authors:  Anne Pizard; Alexandre Gueret; Guillaume Galmiche; Soumaya El Moghrabi; Antoine Ouvrard-Pascaud; Stefan Berger; Pascal Challande; Iris Z Jaffe; Carlos Labat; Patrick Lacolley; Frédéric Jaisser
Journal:  Hypertension       Date:  2013-12-02       Impact factor: 10.190

7.  Multimarker approach to evaluate correlates of vascular stiffness: the Framingham Heart Study.

Authors:  Wolfgang Lieb; Martin G Larson; Emelia J Benjamin; Xiaoyan Yin; Geoffrey H Tofler; Jacob Selhub; Paul F Jacques; Thomas J Wang; Joseph A Vita; Daniel Levy; Ramachandran S Vasan; Gary F Mitchell
Journal:  Circulation       Date:  2008-12-22       Impact factor: 29.690

8.  Inadequate RAAS suppression is associated with excessive left ventricular mass and systo-diastolic dysfunction.

Authors:  Mario Gregori; Giuliano Tocci; Andrea Marra; Giulia Pignatelli; Caterina Santolamazza; Alberto Befani; Giuseppino Massimo Ciavarella; Andrea Ferrucci; Francesco Paneni
Journal:  Clin Res Cardiol       Date:  2013-06-14       Impact factor: 5.460

Review 9.  Aldosterone and vascular mineralocorticoid receptors: regulators of ion channels beyond the kidney.

Authors:  Jennifer J DuPont; Michael A Hill; Shawn B Bender; Frederic Jaisser; Iris Z Jaffe
Journal:  Hypertension       Date:  2013-12-30       Impact factor: 10.190

10.  Hypertension of Kcnmb1-/- is linked to deficient K secretion and aldosteronism.

Authors:  P Richard Grimm; Debra L Irsik; Deann C Settles; J David Holtzclaw; Steven C Sansom
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.